Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Obstructive Lung Diseases

  Free Subscription

Articles published in Thorax

Retrieve available abstracts of 60 articles:
HTML format

Single Articles

    November 2022
  1. TYDEMAN F, Pfeffer PE, Vivaldi G, Holt H, et al
    Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).
    Thorax. 2022 Nov 23:thorax-2022-219591. doi: 10.1136/thorax-2022-219591.
    PubMed     Abstract available

  2. GAUTAM Y, Mersha TB
    Leveraging genetic ancestry to study severe asthma exacerbations in an admixed population.
    Thorax. 2022 Nov 18. pii: thorax-2022-219459. doi: 10.1136/thorax-2022-219459.

    Environmental exposures: another effect on sphingolipids in asthma?
    Thorax. 2022 Nov 11. pii: thorax-2022-219479. doi: 10.1136/thorax-2022-219479.

  4. ALLAM VSRR, Pavlidis S, Liu G, Kermani NZ, et al
    Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma.
    Thorax. 2022 Nov 7. pii: thorax-2021-218555. doi: 10.1136/thorax-2021-218555.
    PubMed     Abstract available

  5. KONSTANTINOUDIS G, Minelli C, Vicedo-Cabrera AM, Ballester J, et al
    Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007-2018.
    Thorax. 2022;77:1098-1104.
    PubMed     Abstract available

  6. DA SILVA SENA CR, de Queiroz Andrade E, de Gouveia Belinelo P, Percival E, et al
    Higher exhaled nitric oxide at 6 weeks of age is associated with less bronchiolitis and wheeze in the first 12 months of age.
    Thorax. 2022;77:1106-1112.
    PubMed     Abstract available

  7. MEGHJI J, Mortimer K, Mpangama S
    TB and COPD in low-income settings: a collision of old foes.
    Thorax. 2022;77:1057-1058.

  8. KAMENAR K, Hossen S, Gupte AN, Siddharthan T, et al
    Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies.
    Thorax. 2022;77:1088-1097.
    PubMed     Abstract available

  9. AHMADIAN S, Sin DD, Lynd L, Harrison M, et al
    Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.
    Thorax. 2022;77:1079-1087.
    PubMed     Abstract available

    September 2022
  10. HERRERA-LUIS E, Mak ACY, Perez-Garcia J, Martin-Gonzalez E, et al
    Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth.
    Thorax. 2022 Sep 30. pii: thorax-2022-218755. doi: 10.1136/thorax-2022-218755.
    PubMed     Abstract available

  11. HALL I, Walker S, Holgate ST
    Respiratory research in the UK: investing for the next 10 years.
    Thorax. 2022;77:851-853.

    August 2022
  12. CARRARO S, Ferraro VA, Zanconato S
    From bronchiolitis endotyping to asthma risk assessment.
    Thorax. 2022 Aug 19. pii: thorax-2022-219388. doi: 10.1136/thorax-2022-219388.

  13. SOREMEKUN S, Heaney LG, Skinner D, Bulathsinhala L, et al
    Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.
    Thorax. 2022 Aug 3. pii: thorax-2021-217032. doi: 10.1136/thorax-2021-217032.
    PubMed     Abstract available

  14. KUNOE A, Sevelsted A, Chawes BLK, Stokholm J, et al
    Height and bone mineral content after inhaled corticosteroid use in the first 6 years of life.
    Thorax. 2022;77:745-751.
    PubMed     Abstract available

  15. BURNS KEA, Stevenson J, Laird M, Adhikari NKJ, et al
    Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis.
    Thorax. 2022;77:752-761.
    PubMed     Abstract available

  16. KIM N, Kwak G, Rodriguez J, Livraghi-Butrico A, et al
    Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
    Thorax. 2022;77:812-820.
    PubMed     Abstract available

    July 2022
  17. CRUMP C, Sundquist J, Sundquist K
    Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study.
    Thorax. 2022 Jul 30. pii: thorax-2022-218931. doi: 10.1136/thorax-2022-218931.
    PubMed     Abstract available

  18. FUJIOGI M, Zhu Z, Raita Y, Ooka T, et al
    Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Thorax. 2022 Jul 30. pii: thorax-2022-219016. doi: 10.1136/thorax-2022-219016.
    PubMed     Abstract available

  19. KEARNS N, Williams M, Bruce P, Black M, et al
    Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial.
    Thorax. 2022 Jul 18. pii: thorax-2022-219052. doi: 10.1136/thorax-2022-219052.
    PubMed     Abstract available

  20. FARNE H, Lin L, Jackson DJ, Rattray M, et al
    In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection.
    Thorax. 2022 Jul 5. pii: thoraxjnl-2021-217389.
    PubMed     Abstract available

  21. D'CRUZ RF, Kaltsakas G
    Does impaired respiratory function lead to sudden cardiac death?
    Thorax. 2022;77:641-642.

  22. NICI L
    Improving the lives of individuals with chronic respiratory disease: the need for innovation.
    Thorax. 2022;77:636-637.

  23. DAYNES E, Greening N, Singh SJ
    Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD.
    Thorax. 2022;77:690-696.
    PubMed     Abstract available

  24. COX NS, McDonald CF, Mahal A, Alison JA, et al
    Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial.
    Thorax. 2022;77:643-651.
    PubMed     Abstract available

  25. CHENG YJ, Chen ZG, Yao FJ, Liu LJ, et al
    Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study.
    Thorax. 2022;77:652-662.
    PubMed     Abstract available

    June 2022
  26. SHIMA H, Tanabe N, Oguma A, Shimizu K, et al
    Subtyping emphysematous COPD by respiratory volume change distributions on CT.
    Thorax. 2022 Jun 29. pii: thoraxjnl-2021-218288.
    PubMed     Abstract available

  27. NAIR AA, Rv L, Christopher DJ
    'Pulmonary tuberculosis presenting as massive spontaneous pneumomediastinum and subcutaneous emphysema'.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2022-218908.

  28. WU CC, Wang CC, Chung WY, Sheu CC, et al
    Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study.
    Thorax. 2022 Jun 16. pii: thoraxjnl-2021-218396.
    PubMed     Abstract available

  29. PASCHALAKI K, Rossios C, Pericleous C, MacLeod M, et al
    Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD.
    Thorax. 2022;77:616-620.
    PubMed     Abstract available

  30. JANSON C
    Inhaled corticosteroids in COPD: risk and benefits.
    Thorax. 2022;77:530-531.

  31. EKLOF J, Ingebrigtsen TS, Sorensen R, Saeed MI, et al
    Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease.
    Thorax. 2022;77:573-580.
    PubMed     Abstract available

    May 2022
  32. WANG AL, Lahousse L, Dahlin A, Edris A, et al
    Novel genetic variants associated with inhaled corticosteroid treatment response in older adults with asthma.
    Thorax. 2022 May 2. pii: thoraxjnl-2021-217674.
    PubMed     Abstract available

    April 2022
  33. MOITRA S, Carsin AE, Abramson MJ, Accordini S, et al
    Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS.
    Thorax. 2022 Apr 27. pii: thoraxjnl-2021-217867.
    PubMed     Abstract available

  34. ANNANGI S, Nutalapati S, Sturgill J, Flenaugh E, et al
    Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease.
    Thorax. 2022;77:351-356.
    PubMed     Abstract available

    March 2022
  35. DOLBY T, Nafilyan V, Morgan A, Kallis C, et al
    Relationship between asthma and severe COVID-19: a national cohort study.
    Thorax. 2022 Mar 30. pii: thoraxjnl-2021-218629.
    PubMed     Abstract available

  36. BARBER CM, Cullinan P, Feary J, Fishwick D, et al
    British Thoracic Society Clinical Statement on occupational asthma.
    Thorax. 2022 Mar 21. pii: thoraxjnl-2021-218597.

  37. GYSENS F, Mestdagh P, de Bony de Lavergne E, Maes T, et al
    Unlocking the secrets of long non-coding RNAs in asthma.
    Thorax. 2022 Mar 4. pii: thoraxjnl-2021-218359.
    PubMed     Abstract available

  38. STANDL M
    Limited side effects of asthma treatment on growth and bone health in children.
    Thorax. 2022 Mar 4. pii: thoraxjnl-2021-218531.

  39. KEIRSBULCK M, Savoure M, Lequy E, Chen J, et al
    Long-term exposure to ambient air pollution and asthma symptom score in the CONSTANCES cohort.
    Thorax. 2022 Mar 2. pii: thoraxjnl-2021-218344.
    PubMed     Abstract available

  40. Correction: Association of asthma severity and educational attainment at age 6-7 years in a birth cohort: population-based record-linkage study.
    Thorax. 2022;77:e2.

  41. STONE PW, Adamson A, Hurst JR, Roberts CM, et al
    Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
    Thorax. 2022;77:239-246.
    PubMed     Abstract available

  42. CHENG SWM, Alison J, Stamatakis E, Dennis S, et al
    Six-week behaviour change intervention to reduce sedentary behaviour in people with chronic obstructive pulmonary disease: a randomised controlled trial.
    Thorax. 2022;77:231-238.
    PubMed     Abstract available

    February 2022
  43. WOODCOCK A, Janson C, Rees J, Frith L, et al
    Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.
    Thorax. 2022 Feb 7. pii: thoraxjnl-2021-218088.
    PubMed     Abstract available

  44. GHOSH AJ, Saferali A, Lee S, Chase R, et al
    Blood RNA sequencing shows overlapping gene expression across COPD phenotype domains.
    Thorax. 2022;77:115-122.
    PubMed     Abstract available

  45. EKSTROM M, Johannessen A, Abramson MJ, Benediktsdottir B, et al
    Breathlessness across generations: results from the RHINESSA generation study.
    Thorax. 2022;77:172-177.
    PubMed     Abstract available

    January 2022
  46. HOPKINSON NS, Lenney W, Langton-Hewer S, Bennett J, et al
    Children's charter for lung health.
    Thorax. 2022;77:11-12.

  47. BECKER EJ, Faiz A, van den Berge M, Timens W, et al
    Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD.
    Thorax. 2022;77:31-39.
    PubMed     Abstract available

    December 2021
  48. NIELSEN MB, Nordestgaard BG, Benn M, Colak Y, et al
    Plasma adiponectin and risk of asthma: observational analysis, genetic Mendelian randomisation and meta-analysis.
    Thorax. 2021 Dec 23. pii: thoraxjnl-2021-217675.
    PubMed     Abstract available

  49. FOO CT, Karia S, Herre J
    Reversible bronchiectasis.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217548.

  50. O'BRIEN ME, Zou RH, Hyre N, Leader JK, et al
    CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217710.
    PubMed     Abstract available

  51. AMARAL AFS, Burney PGJ, Patel J, Minelli C, et al
    Chronic airflow obstruction and ambient particulate air pollution.
    Thorax. 2021;76:1236-1241.
    PubMed     Abstract available

    November 2021
  52. LEE JH, Kim TB
    Eosinophil granule proteins: what they can tell us about asthma.
    Thorax. 2021 Nov 26. pii: thoraxjnl-2021-218268.

  53. BEDI P, Ziegler K, Whitfield PD, Davidson D, et al
    Dysregulation of prostaglandins, leukotrienes and lipoxin A4 in bronchiectasis.
    Thorax. 2021 Nov 17. pii: thoraxjnl-2020-216475.
    PubMed     Abstract available

  54. STEWART I, Bloom CI
    Considerations for conducting and interpreting long-term follow-up of intervention studies: avoiding spoiled milk.
    Thorax. 2021;76:1067-1068.

  55. POLOSUKHIN VV, Gutor SS, Du RH, Richmond BW, et al
    Small airway determinants of airflow limitation in chronic obstructive pulmonary disease.
    Thorax. 2021;76:1079-1088.
    PubMed     Abstract available

    October 2021
  56. FARNE H, Glanville N, Johnson N, Kebadze T, et al
    Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.
    Thorax. 2021 Oct 29. pii: thoraxjnl-2021-217429.
    PubMed     Abstract available

  57. CREESE H, Lai E, Mason K, Schluter DK, et al
    Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study.
    Thorax. 2021 Oct 14. pii: thoraxjnl-2021-217312.
    PubMed     Abstract available

  58. GRANGER V, Zerimech F, Arab J, Siroux V, et al
    Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults.
    Thorax. 2021 Oct 6. pii: thoraxjnl-2021-217343.
    PubMed     Abstract available

    September 2021
  59. BAGGOTT C, Hardy JK, Sparks J, Sabbagh D, et al
    Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis.
    Thorax. 2021 Sep 30. pii: thoraxjnl-2021-217124.
    PubMed     Abstract available

  60. KHO AT, McGeachie MJ, Li J, Chase RP, et al
    Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma.
    Thorax. 2021 Sep 27. pii: thoraxjnl-2020-215523.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.